- Home
- PRKS vs TARS Comparison
PRKS vs TARS Comparison
Compare PRKS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- TARS
- Stock Information
- Founded
- PRKS 1959
- TARS 2016
- Country
- PRKS United States
- TARS United States
- Employees
- PRKS N/A
- TARS N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TARS Medicinal Chemicals and Botanical Products
- Sector
- PRKS Health Care
- TARS Health Care
- Exchange
- PRKS Nasdaq
- TARS Nasdaq
- Market Cap
- PRKS 2.8B
- TARS 2.8B
- IPO Year
- PRKS 2013
- TARS 2020
- Fundamental
- Price
- PRKS $51.25
- TARS $67.56
- Analyst Decision
- PRKS Buy
- TARS Strong Buy
- Analyst Count
- PRKS 10
- TARS 7
- Target Price
- PRKS $56.40
- TARS $69.43
- AVG Volume (30 Days)
- PRKS 684.0K
- TARS 613.1K
- Earning Date
- PRKS 11-06-2025
- TARS 11-04-2025
- Dividend Yield
- PRKS N/A
- TARS N/A
- EPS Growth
- PRKS N/A
- TARS N/A
- EPS
- PRKS 3.77
- TARS N/A
- Revenue
- PRKS $1,707,446,000.00
- TARS $295,521,000.00
- Revenue This Year
- PRKS $0.91
- TARS $139.46
- Revenue Next Year
- PRKS $2.35
- TARS $49.91
- P/E Ratio
- PRKS $13.59
- TARS N/A
- Revenue Growth
- PRKS N/A
- TARS 254.45
- 52 Week Low
- PRKS $37.68
- TARS $38.51
- 52 Week High
- PRKS $60.83
- TARS $76.81
- Technical
- Relative Strength Index (RSI)
- PRKS 46.88
- TARS 54.32
- Support Level
- PRKS $49.69
- TARS $65.30
- Resistance Level
- PRKS $52.03
- TARS $74.83
- Average True Range (ATR)
- PRKS 1.77
- TARS 2.87
- MACD
- PRKS -0.24
- TARS -0.99
- Stochastic Oscillator
- PRKS 31.26
- TARS 19.64
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.